BRCA genes Modena criteria breast cancer hereditary cancer ovarian cancer prostate cancer

Journal

Cancer biology & medicine
ISSN: 2095-3941
Titre abrégé: Cancer Biol Med
Pays: China
ID NLM: 101588850

Informations de publication

Date de publication:
12 Mar 2021
Historique:
entrez: 12 3 2021
pubmed: 13 3 2021
medline: 13 3 2021
Statut: aheadofprint

Résumé

As prostate cancer (PrC) shows a Following the Modena criteria for the Among 6,591 families, 580 (8.8%) with a Gleason score ≥ 7 PrCs were identified, of which 332 (57.2%) met the Modena selection criteria for BRCA testing. Overall, 215 breast or ovarian cancer probands (64.8%) were tested, of which 41 resulted positive for It appears the Modena criteria are very useful for BRCA testing selection in families with breast and/or ovarian cancer and PrC. A trend toward a worse prognosis has been found in

Identifiants

pubmed: 33710808
pii: j.issn.2095-3941.2020.0481
doi: 10.20892/j.issn.2095-3941.2020.0481
pmc: PMC8185862
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 Cancer Biology & Medicine.

Déclaration de conflit d'intérêts

Laura Cortesi holds an honoraria from AstraZeneca, MSD, Pfizer and a consulting or advisory role at Pfizer, Novartis, Tesaro and Clovis. Angela Toss holds a consulting or advisory role at Lilly and Novartis.

Références

World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
World J Urol. 2016 Aug;34(8):1115-22
pubmed: 26658661
J Korean Med Sci. 2017 Feb;32(2):377-381
pubmed: 28049253
BMC Cancer. 2006 Aug 17;6:210
pubmed: 16916448
Eur Urol. 2019 Dec;76(6):831-842
pubmed: 31537406
Br J Dermatol. 2015 Sep;173(3):731-8
pubmed: 25913354
J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6
pubmed: 10433620
Am J Hum Genet. 2003 May;72(5):1117-30
pubmed: 12677558
Br J Cancer. 2002 Oct 7;87(8):888-91
pubmed: 12373604
Hum Mutat. 2012 Jan;33(1):2-7
pubmed: 21990146
JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
MedGenMed. 2005 Jun 29;7(2):60
pubmed: 16369438
Genes (Basel). 2020 Mar 14;11(3):
pubmed: 32183364
Asian J Androl. 2012 May;14(3):409-14
pubmed: 22522501
Breast Cancer Res Treat. 1999 Jun;55(3):213-21
pubmed: 10517166
Cancer Res. 2020 Feb 1;80(3):624-638
pubmed: 31723001
Ann Oncol. 2015 Apr;26(4):756-761
pubmed: 25595936
Cancer Med. 2020 Apr;9(7):2579-2589
pubmed: 32045136
Br J Cancer. 2008 Jul 22;99(2):371-4
pubmed: 18577985
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Natl Cancer Inst. 2002 Sep 18;94(18):1365-72
pubmed: 12237282
Am J Hum Genet. 1998 Mar;62(3):676-89
pubmed: 9497246

Auteurs

Laura Cortesi (L)

Department of Oncology and Hematology, University Hospital of Modena, Modena 41124, Italy.

Federica Domati (F)

Department of Medical and Surgical Sciences for Children & Adults, Division of Medical Oncology, University Hospital of Modena, Modena 41124, Italy.

Annalisa Guida (A)

Department of Medical and Surgical Sciences for Children & Adults, Division of Medical Oncology, University Hospital of Modena, Modena 41124, Italy.

Isabella Marchi (I)

Department of Oncology and Hematology, University Hospital of Modena, Modena 41124, Italy.

Angela Toss (A)

Department of Medical and Surgical Sciences for Children & Adults, Division of Medical Oncology, University Hospital of Modena, Modena 41124, Italy.

Elena Barbieri (E)

Department of Oncology and Hematology, University Hospital of Modena, Modena 41124, Italy.

Luigi Marcheselli (L)

Department of Medical and Surgical Sciences for Children & Adults, Division of Medical Oncology, University Hospital of Modena, Modena 41124, Italy.

Marta Venturelli (M)

Department of Medical and Surgical Sciences for Children & Adults, Division of Medical Oncology, University Hospital of Modena, Modena 41124, Italy.

Simonetta Piana (S)

Pathology Unit, Azienda USL Reggio Emilia, IRCCS, Reggio Emilia 42123, Italy.

Claudia Cirilli (C)

Modena Cancer Registry, Public Health Department, AUSL Modena 41126, Italy.

Massimo Federico (M)

Department of Medical and Surgical Sciences for Children & Adults, Division of Medical Oncology, University Hospital of Modena, Modena 41124, Italy.

Classifications MeSH